Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | CA4 | P22748 | 3/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA6 | P23280 | 2/20 | 0.39 |
| ▸ | CA5A | P35218 | 2/20 | 0.39 |
| ▸ | CA7 | P43166 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | HPGD | P15428 | 4/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11415742 | 0.87 | CA1 (0.44) | CYP3A4TRPV4CA1CA2CA4 | |
| SCHEMBL29859906 | 0.82 | CYP3A4 (0.50) | CYP3A4CA1CA2CA4CA12 | |
| SCHEMBL17310965 | 0.82 | CYP3A4 (0.50) | CYP3A4CA1CA2CA4CA12 | |
| SCHEMBL11757766 | 0.79 | TRPV4 (0.36) | TRPV4CA1CA2CA4CA12 | |
| SCHEMBL1991714 | 0.78 | TRPV4 (0.50) | TRPV4CA1CA2CA4CA12 | |
| SCHEMBL11154927 | 0.78 | CYP3A4 (0.46) | CYP3A4TRPV4CA1CA2CA4 | |
| SCHEMBL29683254 | 0.78 | ALDH1A1 (0.50) | CYP3A4TRPV4CA1CA2CA4 | |
| SCHEMBL5839608 | 0.78 | CYP3A4 (0.46) | CYP3A4CA1CA2CA4CA12 | |
| SCHEMBL5704866 | 0.78 | ALDH1A1 (0.50) | CYP3A4TRPV4CA1CA2CA4 | |
| SCHEMBL2268180 | 0.76 | CA1 (0.55) | CYP3A4TRPV4CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7009077-B2 | Aromatic sulfonation reactions | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2006-03-07 | — | — | US | disclosed |
| EP-1324982-B1 | AROMATIC SULFONATION REACTIONS | UNIV BELFAST (GB) | 2004-12-08 | — | — | EP | disclosed |
| US-20040242932-A1 | Aromatic sulfonation reactions | QUEEN'S UNIVERSITY OF BELFAST, THE (GB) | 2004-12-02 | — | — | US | disclosed |
| EP-1324982-A1 | AROMATIC SULFONATION REACTIONS | The Queen's University of Belfast (GB) | 2003-07-09 | — | — | EP | disclosed |
| WO-2002030878-A1 | AROMATIC SULFONATION REACTIONS | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2002-04-18 | — | — | WO | disclosed |
| US-4246188-A | Arylsulfonic acid bromophenyl esters, their preparation, and their use as flameproofing agents | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) | 1981-01-20 | — | — | US | disclosed |
| US-4116934-A | Arylsulfonic acid bromophenyl esters, their preparation, and their use as flameproofing agents | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) | 1978-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040242932-A1 | Aromatic sulfonation reactions | ARSA, TYR, TST | CYP3A4 24/4885TRPV4 886/4885CA1 3231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.